STUDY 3: Reduction of Joint Deterioration and Discomfort in 6 areas. – ReGenos

STUDY 3: Reduction of Joint Deterioration and Discomfort in 6 areas.


Thoughts from ReGenos President, Jim Kent

Setup:

  • 147 Participants (97 completed/evaluated)
  • Areas studied: joint pain at rest, when walking, when standing, at rest (evaluated by a physician), when carrying objects, and when lifting.
  • 24 week study
  • 10 g daily dose (See note below)

Results:

  • When data from all subjects (n =97) were evaluated, six parameters showed statistically significant changes with the dietary supplement collagen hydrolysate (CH) compared with placebo.
  • 78% of the subjects in this study reported improved symptoms with reduction of pain on movement in 12 weeks.

Conclusion:

  • results suggest that athletes consuming collagen hydrolysate can reduce parameters (such as pain) that have a negative impact on athletic performance.
  • Sponsored by Gelita AG

Read the Full Study here

Note: a later study (Zdzieblik 2017) reduced the intake to 5 grams and found no statistical difference in the results. That study is here. The excerpt is on page 5 where it says: "..the daily dosage was reduced from 10 to 5 g, and the duration of the treatment was shortened from 24 to 12 weeks." it goes on to say: "the efficacy of the collagen peptide intake seems to be independent from BMI of the subjects. This indicates that a daily intake of 10 g might not be required..."